Singapore, Nov. 17 -- Australia's new national incubator for vaccine and infectious disease innovation, Biointelect Venturer, has been launched, backed by $32.9 million in funding from the Australian Government's Medical Research Future Fund (MRFF)under the 2024 BioMedTech Incubator Grant Opportunity.

The initiative aims to transform early-stage scientific breakthroughs into viable health solutions with meaningful public health impact. Over four years (2026-2029), Biointelect Venturer will support three cohorts of innovators, providing Australian small and medium enterprises (SMEs) with the opportunity to advance vaccine and infectious disease innovations and attract further investment.

Successful applicants in the first cohort will beg...